To include your compound in the COVID-19 Resource Center, submit it here.

EpiTherapeutics: Built BRIC by BRIC

EpiTherapeutics leveraging Danish academic engine for new epigenetic targets

While EpiTherapeutics ApS is one of at least three companies founded since 2007 to work on histone methyltransferases or histone demethylases, the Danish biotech believes there are plenty of targets to go around.

It also thinks its access to a highly prolific academic research engine will set it apart from companies working on the same classes of epigenetic targets.

EpiTherapeutics was spun out of the University of Copenhagen's Biotech Research and Innovation Center

Read the full 710 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers